With the COVID-19 pandemic showing no signs of abating, resuming neglected tropical disease activities, particularly mass drug administration, is vital in achieving WHO Roadmap targets.
The Ascend Learning and Innovation Fund is funding projects to accelerate the control and elimination efforts of neglected tropical diseases.
RAMA is a new risk assessment and mitigation action tool enabling us and government partners to mitigate the risk of spreading COVID-19 and restart treatment.
Moses Chege, Sightsavers Kenya country director, explains how Sightsavers and partners were able to reach the worst-effected people suffering from trachoma.
Nigeria is the first Sightsavers-supported country to resume treatments for neglected tropical diseases (NTDs) since April due to COVID-19.
Sightsavers and partners delivered 11.7 million trachoma treatments and carried out nearly 32,000 trichiasis surgeries in two years under the Commonwealth Fund.
A Sightsavers-led programme in Africa has surpassed several of its first-year targets as it delivers more than 127 million drug treatments for five debilitating neglected tropical diseases (NTDs).
We speak to Tropical Data’s data analyst, Sarah Boyd, to find out what she and the team have been working on while travel hasn’t been possible and many of us have been advised to stay at home.
In the first year of the programme, the Ascend West and Central Africa partners have supported health workers and volunteers to deliver mass treatment campaigns that will help tackle high rates of neglected tropical diseases (NTDs) in Liberia.
Paolo's family could not understand why he kept having problems with his eyes. Thankfully, training for a Sightsavers-supported programme was taking place nearby.